Telomir Pharmaceuticals TELO
NASDAQ TELO
$1.17 -0.03 (-2.50%)
At close: Oct 1, 2026 · 4:00 PM EDT

Telomir Pharmaceuticals (TELO) Net Equity Issued and Repurchased (2023 - 2026)

Updated

Telomir Pharmaceuticals (TELO) recorded Net Equity Issued and Repurchased of $1,032 in Q2 2026.

Analysis

Telomir Pharmaceuticals (TELO) Net Equity Issued and Repurchased (2023 - 2026) Analysis & Trends

On a TTM basis, Telomir Pharmaceuticals' Net Equity Issued and Repurchased came in at -$1.29 million as of Jun 30, 2026; for FY2024, it was $37,300, down 96.3% from FY2023.

  • Across earlier years, Net Equity Issued and Repurchased came in at $1 million in FY2023.
  • The Q2 2026 figure is the lowest quarterly Net Equity Issued and Repurchased since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Telomir Pharmaceuticals 82.53 Mn 82.53 Mn - 1,032.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,032.00
Sep 30, 2025 4.50 Mn
Dec 31, 2024 -5.80 Mn
Mar 31, 2024 5.83 Mn
Dec 31, 2023 90,000.00
Jun 30, 2023 -90,000.00
Mar 31, 2023 1.00 Mn
API Access

Telomir Pharmaceuticals Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=TELO&period=max&api_key=YOUR_API_KEY